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Abstract
A batch system and a flow system with synthetic water were used to study calcium carbonate precipitation and phytate crys-
tallisation inhibitory effects. Afterwards, phytate inhibitory effects on calcium carbonate crystallisation were tested in a real 
system, working with a cistern filled with hard water. Finally, the effects of phytate on calcium carbonate crystallisation were 
compared with another phosphate derivative and with a chelating agent.
 The results obtained with the batch system demonstrated that 1.52 µM of phytate completely avoided calcium carbonate 
crystallisation when the calcium concentration was less than 7.9 mM and the carbonate concentration was 5.83 mM. The 
results corresponding to the flow system showed that 3.03 µM of phytate led to a 95% reduction of calcium carbonate scale 
formation on a copper pipe after 48 h, operating at 30ºC. In addition, in a full-scale system, the dissolved calcium and bicar-
bonate concentration was increased for a given time when adding phytate to the cistern. Finally, using a batch system, it was 
demonstrated that phytate effects on calcium carbonate crystallisation reduction were superior to those shown by triphos-
phate and EDTA.
  The results presented demonstrate that phytate at very low concentrations can be used to prevent calcium carbonate scale 
formation without changing the mineral composition of water due to its capacity as a crystallisation inhibitor.
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Introduction
The driving force for crystallisation is supersaturation. Thermo-
dynamically, a supersaturated system is unstable, and depend-
ing on kinetic factors (promoters or crystallisation inhibitors) 
solids formation will be enhanced or delayed. Water hardness 
can lead to scale formation, consisting primarily of CaCO3 but 
including other salts such as CaSO4, resulting from high super-
saturation. This problem is critical in systems working at high 
temperatures, such as boilers. In these systems hard water can-
not be used, because of the risks of breakages and explosions.
		 Calcium carbonate is the most abundant mineral in nature 
(Sikes, 1988) and is present as three polymorphic varieties, cal-
cite, aragonite and vaterite. Morphological control of calcium 
carbonate can be achieved using different additives (Kang, 
2005; Kim, 2005; Hou, 2005). Among the water-softening 
methods proposed to avoid calcium carbonate scale forma-
tion are ionic exchangers, consisting of zeolites (Malik, 2001; 
Semenov, 2004) and ion-exchange resins (Gwon, 2002); reverse 
osmosis systems (Hirayama, 1990); and the formation of sta-
ble complexes with EDTA (Westin, 2005) and phosphates such 
as tripolyphosphate (Arai 1968). Recently, electrodialysis has 
been used to remove calcium and magnesium from solutions 
(Toti, 2000; Kabay, 2002).
 Calcium carbonate precipitation can also be reduced or 
delayed by using so-called crystallisation inhibitors. These 
substances prevent or disturb precipitation by adsorbing onto 
the surfaces of nuclei as they form or onto the faces of growing 
crystals, respectively, thereby modifying the kinetics of crystal-
lisation. Among the agents described as calcium carbonate crys-
tallisation inhibitors are ions such as Fe2+, Fe3+, Mg2+	and	Zn2+	
(Reddy, 1980; Macadam, 2004; Hasson, 2004; Coetzee, 1998).
 Calcium carbonate crystallisation has also been widely stud-
ied using the inhibitory properties of other compounds, among 
them phosphates and phosphonates (Reddy (1972; 1973); Nan-
collas, 1975), aminophosphonates (Guo, 2004), polyacrylic acid 
(Klepetsanis (1999; 2000)), and copolymers containing maleic 
acid (Klepetsanis, 1998). 
	 Myo-inositol hexakisphosphate (phytate) is a power-
ful inhibitor of the crystallisation of calcium salts and has 
been shown to prevent calcium renal lithiasis (Grases (1999; 
2000a)). Phytate levels found in tissues reflect dietary intake 
(Grases (2001a; 2001b)). Previous work has found that phytate 
only manifested toxic effects at very high doses (the LD50	
value for male rats was 1.3 mmol·kg-1 administered orally as 
sodium phytate (Ichikawa, 1987). Administration of phytate 
as the natural food salt (phytin: calcium magnesium phytate) 
at amounts that provide maximum absorption equivalent to 
doses that correspond to the consumption of the so-called 
‘Mediterranean diet’ (1 to 2 g phytate/d) were not found to 
have any chronic effect (Grases, 2004).  Furthermore, in 
the field of renal lithiasis and cardiovascular calcifications 
it is the most effective crystallisation inhibitor of calcium 
oxalate (Grases (1994; 1996a; 1996b)), its efficacy on brushite 	
(calcium phosphate) even being superior to other phosphate 
derivatives such as pyrophosphate, hexametaphosphate, etidro-
nate or triphosphate (Grases (2000b; 2007)). All these data led 
us to believe that  phytate could be used as an alternative to scale 
prevention and we therefore assayed the crystallisation inhibi-
tion properties of phytate on calcium carbonate solids formation 
by adding it to supersaturated water.
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Methods
Preparation of synthetic hard water
Synthetic hard water was prepared by mixing equal volumes of 
Solutions A and B, as shown in Table 1. Solution A was stored 
for a maximum of 1 week at 4ºC, and Solution B was always 
prepared immediately before use. Chemicals of reagent-grade 
purity were dissolved in deionised, redistilled water. All solu-
tions were filtered through a 0.45 µm pore filter before use.
Calcium carbonate precipitation using a batch 
system and study of phytate crystallisation inhibitory 
effects
To study calcium carbonate crystal formation in synthetic hard 
water, turbidimetric measurements were performed by means of 
a photometer (Metrohm 662) equipped with a fibre-optic light 
guide measuring cell with an attached light path 2 x 10 mm 
reflector, using monochromatic light (550 nm). Crystallisation 
processes were performed at 25ºC using cylindrical tubes (height 
100 mm, inner diameter 150 mm). Five mℓ of Solution A were 
added to the crystallisation tube, followed by 5 mℓ of freshly 
prepared Solution B; the pH of each solution was adjusted to 
8.3 with diluted HCl or NaOH. The tube was immediately stop-
pered and the solution was stirred to homogeneously distribute 
the precipitates. The absorbance was measured after 15 s and 	
1 h later. Final calcium concentration ranged between 0.4 to 12.9 
mM.  Precipitations were carried out at phytate concentrations 
of 0 to 3.03 µM.  
 The solids formed under these experimental conditions were 
filtered and dissolved in 1 M HCl and total dissolved calcium and 
magnesium were determined by atomic emission spectrometry, 
using an inductively coupled plasma (Perkin-Elmer SL, Optima 
5300DV) spectrometer. Calcium carbonate crystals formed after 
1 h were filtered, dried in a desiccator and analysed using a scan-
ning electron microscope equipped with an energy dispersive 
X-ray analyser (EDS).
Calcium carbonate precipitation using a flow system 
and study of phytate crystallisation inhibitory effects
Synthetic hard water was recirculated by a multi-channel peri-
staltic pump for 48 h at a flow rate of 4 mℓ/min through a copper 
pipe of 200 mm length, 4 mm inner diameter and 6 mm outer 
diameter (Fig. 1). Synthetic hard water was changed after 24 h 
to reduce the effects of supersaturation changes due to crystal 
deposition on the pipe walls. Crystallisation was performed at a 
temperature of 30 and 65ºC.
 Final calcium concentration ranged from 2.9 to 5.4 mM and 
the pH of both solutions was adjusted to 8.0. Precipitation was 
carried out at phytate concentrations of 0 to 4.55 µM.
 After 48 h the precipitate on the pipe walls was dissolved 
in 1 M HCl and the calcium concentration was determined by 
atomic emission spectrometry using an inductively coupled 
plasma (Perkin Elmer Optima 5300 DV) spectrometer.
Full-scale system to study phytate crystallisation 
inhibitory effects on calcium carbonate precipitation
A cistern with a capacity of 10 000 ℓ (supplying water to three 
families) was used to study the inhibitory capacity of phytate 
in a real system. The cistern was refilled weekly from a natu-
ral well filled with hard water. Upon filling the cistern, phytate 	
(as a potassium salt) was added to a final concentration of 0 to 
1.52 µM. After 2 d of filling, a water sample was collected from 
a tap of one of the families, and its pH and calcium and bicarbo-
nate concentrations were measured.
Comparison of the effects of phytate, triphosphate 
and EDTA on calcium carbonate precipitation 
reduction using a batch system
To compare the effects of phytate, triphosphate (as sodium 
salt) and EDTA (as sodium salt) on calcium carbonate crystal-
lisation, kinetic turbidimetric measurements were performed 
by means of a photometer (Metrohm 662) equipped with a 
fibre-optic light guide measuring cell with an attached light 
path 2 x 10 mm reflector, using monochromatic light (550 nm). 
Crystallisation processes were carried out in a thermostated 
(25ºC) and magnetically stirred cylindrical glass flask (height 
12.5 cm, diameter 9 cm). 250 mℓ of a 6 mM CaCl2 solution 
were added to the crystallisation flask, the measuring cell 
was immersed in the solution and the magnetic stirrer was 
switched on. Then 250 mℓ of a solution of 11.67 mM NaHCO3	
were added. Final calcium and carbonate concentrations were 
3 mM and 5.82 mM respectively. The pH of both solutions was 
adjusted to 8.5 with diluted HCl or NaOH. The range of addi-
tives concentrations assayed were 0 to 3.03 µM for phyate, 0 
to 408 µM for triphosphate and 0 to 2 000 µM for EDTA, the 
chart recorder was immediately switched on in order to print 
the absorbance-time curve. A diagram of the experimental 
device used is shown in Fig. 2.
Figure 1
Diagram of the experimental flow system used to study calcium 
carbonate crystallisation. 1. Temperature-controlled chamber;  
2. Peristaltic pump; 3. Copper pipe; 4. Synthetic hard water
TABLE 1
Composition of synthetic hard water
Solution A (µM) Solution B (µM)
MgSO4·7H2O 162.3 MgSO4·7H2O 162.3
KNO3 29.7 KNO3 29.7
Ca(NO3)2·2H2O 400 Ca(NO3)2·2H2O 400
CuSO4·5H2O 0.802 CuSO4·5H2O 0.802
ZnCl2 14.66 ZnCl2 14.66 
CaCl2 0-12 500 NaHCO3 11 670
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Results and discussion
Throughout these experiments, controls were utilised, consist-
ing of inhibitor concentration 0 µM, with each water matrix to 
ensure that the reduction of calcium carbonate crystallisation 
was due only to the effects of phytate and not to other com-
pounds.
 Using the batch system, it was found that only calcium 
carbonate was formed, with no precipitation of mixed magne-
sium salts. Scanning electron microscopy (SEM) of the calcium 
carbonate crystals formed after 1 h revealed that the crystal-
lographic structure corresponded to calcite (Fig. 3), with no 
magnesium present in the precipitated samples. Addition of 1.52 
µM phytate to the synthetic hard water completely inhibited cal-
cium carbonate precipitation when calcium concentrations were 
below 6.65 mM and when the carbonate concentration was 5.83 
mM (Fig. 4). Drinkable hard water contains 2.5 to 3 mM cal-
cium and 3.33-8.33 mM carbonate, and has a pH of 6.5 to 8.5. 
Thus, 1.52 µM phytate can inhibit crystallisation of calcium car-
bonate in drinkable hard water. The reduction in crystallisation 
is probably not due to the formation of Ca-phytate complexes, 
since phytate is present at a 1 000-fold lower concentration than 
calcium. 
 The results obtained using the flow system are shown in 
Tables 2 and 3 and Fig. 5. This experimental device was designed 
using conditions as close as possible to actual concentrations of 
calcium (2.9 to 5.4 mM) and pH (8.0). The amount of CaCO3	
precipitated was directly related to the calcium concentration in 
the synthetic water. In the presence of 2.9, 3.4 and 5.4 mM of 
calcium, 3.03 µM phytate reduced the degree of CaCO3 scale 
formation on the copper pipe after 48 h by 82.8%, 94.5% and 
95.0%, respectively, at 30ºC. The degree of precipitation was 
higher at 65ºC than at 30ºC, due to an increase in the kinetics of 
crystallisation and the decrease of calcium carbonate solubility 
Figure 2
Diagram of the experimental 
device used to compare the 
effects of phytate, triphosphate 
and EDTA on calcium carbonate 
crystallisation. 1. Recorder; 
2. Altern tension stabiliser; 
3. Photometer equipped with 
a fibre-optic light-guide 
measuring cell; 4. Thermostatic 




Calcite crystals formed using 
a batch system. 
Experimental conditions: pH = 8.3, 
[Ca2+] = 12.9 mM, t = 1 h
Figure 4 (right)
Batch system of calcium carbonate 
precipitation and the inhibitory 
effects of phytate. 
Experimental conditions: a. pH = 8.3, 
t = 15 s. b. pH = 8.3, t = 1 h
(a)
(b)
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at the higher temperature (Table 3). A maximum diminution of 
90.8 % was attained at a calcium concentration of 3.4 mM and a 
phytate concentration of 4.55 µM, again showing that very low 
concentrations of phytate can reduce calcium carbonate forma-
tion in a flowing system.
 The results obtained with a full-scale system, at high cal-
cium and bicarbonate concentrations, are summarised in Table 4. 	
Calcium carbonate precipitation was indirectly evaluated by 
determining the concentrations of dissolved calcium and car-
bonate ions. When calcium carbonate is precipitated, the calcium 
and carbonate concentrations in the cistern should decrease. 
Thus, if precipitation is inhibited by the addition of a crystal-
lisation inhibitor, the calcium and bicarbonate concentrations 
should be higher. We found that increasing the phytate concen-
tration in the cistern increased the concentrations of dissolved 
calcium and bicarbonate, showing that phytate can inhibit for-
mation of calcium carbonate solids due to its ability to inhibit 
crystallisation.
 Comparing the effects of phytate, triphosphate and EDTA 
on calcium carbonate crystallisation (Fig. 6) it can be observed 
that phytate provoked a maximum delay on calcium carbonate 
crystallisation at very reduced concentrations, reaching a time 
of nucleation of 24.3 h with 3.03 µM of phytate. Working with 
EDTA, a concentration of 2 000 µM was necessary to obtain 
the same effect as phytate. This is due to the fact that phytate 
acts as a crystallisation inhibitor whereas the action of EDTA 
is as a chelating agent. The maximum inhibitory effects caused 
by triphosphate were observed with a concentration of 54 µM. 
When increasing the concentration to get a major delay of crys-
tallisation it was found that the nucleation time decreased, prob-
ably due to the crystallisation of calcium phosphate salts. This 
comparison demonstrates that phytate clearly delays the crys-
tallisation of calcium carbonate at concentrations in the micro-
molar range, therefore being superior to triphosphate and EDTA 
(chelating agent) in this regard.
	 Crystallisation inhibitory properties of phytate had been 
previously studied using other calcium salts. It was demon-
strated that phytate is a powerful inhibitor of heterogeneous 
nucleation of calcium oxalate (Grases (1991; 1994)), homoge-
neous nucleation of calcium phosphates (Grases, 1996a) and 
crystal growth of calcium oxalate (Grases, 1989) due to its self-
adsorption on nuclei in formation or on the faces of a grow-
ing crystal. The results with the batch systems presented in 
TABLE 2
Percent inhibition of calcium carbonate precipitation using the flow system at 30ºC 
(n = 3)
[Ca2+] = 2.9 mM [Ca2+] = 3.4 mM [Ca2+] = 5.4 mM
[phytate] (μM) % inhibition [phytate] (μM) % inhibition [phytate] (μM) % inhibition
0 - 0 - 0 -
1.52 67.9 ± 9.2 1.52 89.5 ± 1.9 1.52 82.8 ± 3.9
3.03 82.8 ± 0.7 3.03 94.50 ± 0.04 3.03 95.0 ± 2.1
4.55 82.5 ± 1.0 4.55 92.5 ± 1.3 4.55 93.1 ± 2.6
TABLE 3
Percent inhibition of calcium carbonate 
precipitation using the flow system at 65ºC (n = 3)









0 - 0 -
1.52 53.2 ± 6.4 1.52 71.3 ± 7.2
3.03 76.2 ± 4.8 3.03 81.0 ± 12.5
4.55 82.7 ± 6.2 4.55 90.8 ± 4.5
TABLE 4








0 7.92 2.69 ± 0.02 5.10 ± 0.03
0.15 8.00 2.70 ± 0.01 5.10 ± 0.03
0.38 7.71 2.86 ± 0.09 5.40 ± 0.03*
0.76 7.40 2.84 ± 0.03* 5.70 ± 0.03*
1.52 7.43 3.02 ± 0.01* 5.90 ± 0.03*
* p < 0.05 vs [phytate] = 0 μM
Figure 5
Flow system of calcium carbonate precipitation and the inhibitory 
effects of phytate. Experimental conditions: pH = 8.0, t = 48 h.
a. T = 30ºC  a p < 0.05 vs [phytate] = 0 µM, [Ca2+] = 2.9 mM
    b p < 0.05 vs [phytate] = 0 µM, [Ca2+] = 3.4 mM
    c p < 0.05 vs [phytate] = 0 µM, [Ca2+] = 5.4 mM
b. T = 65ºC  a p < 0.05 vs [phytate] = 0 µM, [Ca2+] = 2.9 mM
    b p < 0.05 vs [phytate] = 0 µM, [Ca2+] = 3.4 mM
(a)
(b)
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this paper, demonstrate that phytate can inhibit homogeneous 
nucleation of calcium carbonate, whereas the results obtained 
working with the flow system show that phytate at very reduced 
concentrations can inhibit heterogeneous nucleation of calcium 
carbonate.
	 Phytate is a natural compound that, at these concentrations, 
is non-toxic. Moreover, it can be beneficial to human health, 
due to its antioxidant, anti-neoplasic properties (Shamsuddin, 
1997; Owen, 1996; Vucenik, 1998) and its prevention of cal-
cium renal lithiasis (Grases (1999; 2000a) and cardiovascular 
calcifications (Grases 2006). Focusing the discussion on water 
treatment, the effect of phytate on inhibiting calcium carbonate 
scale formation is directly related to its effect on calcium renal 
lithiasis and cardiovascular calcifications. In the three cases 
phytate acts as a crystallisation inhibitor by self-adsorption 
on the calcium crystal in formation or growth and, although 
they represent very different research fields they are a conse-
quence of the same chemical effect. Conventional hard water 
treatment methods, including reverse osmosis, precipitation or 
ionic exchangers, are based on reducing supersaturation, elim-
inating the ions responsible for water hardness. Few domestic 
or industrial systems incorporate crystallisation inhibitors to 
reduce the degree of scale formation. Other methods, such as 
the addition of EDTA, may have negative effects on human 
health and the environment. Although phosphorus-containing 
compounds have been used as detergent additives to prevent 
calcium carbonate scale formation, due to the ability of these 
compounds to chelate calcium and magnesium, they can lead 
to eutrophication by increasing phosphate concentration in the 
receiving water bodies. In this paper, we present a methodology 
for hard water treatment based on the incorporation of phytate, 
a crystallisation inhibitor that does not change water super-
saturation with respect to calcium carbonate. Phytate does not 
have a negative impact on the environment (i.e. eutrophication) 
since it inhibits crystallisation rather than acting as a chelat-
ing agent. Thus, the phytate concentrations required to signifi-
cantly reduce the degree of calcium carbonate crystallisation 
are in the micro-molar range.
Conclusions
These results show that very low concentrations of phytate may 
prevent calcium carbonate scale formation due to its ability to 
inhibit crystallisation. At these concentrations, phytate may be 
beneficial for human health, mainly in the field of calcium renal 
lithiasis (Grases, 2000c) and cardiovascular calcifications (Grau, 
2005) and will not have deleterious environmental effects. 
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